Pilocarpine-Isopto 4 % eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pilocarpine-isopto 4 % eye drops sol. dropper cont.

novartis pharma sa-nv - pilocarpine hydrochloride 40 mg/ml - eye drops, solution - 4 % - pilocarpine hydrochloride 40 mg/ml - pilocarpine

Pilocarpine-Isopto 1 % eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pilocarpine-isopto 1 % eye drops sol. dropper cont.

novartis pharma sa-nv - pilocarpine hydrochloride 10 mg/ml - eye drops, solution - 1 % - pilocarpine hydrochloride 10 mg/ml - pilocarpine

Pilocarpine-Isopto 3 % eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pilocarpine-isopto 3 % eye drops sol. dropper cont.

novartis pharma sa-nv - pilocarpine hydrochloride 30 mg/ml - eye drops, solution - 3 % - pilocarpine hydrochloride 30 mg/ml - pilocarpine

PILOCARPINE HYDROCHLORIDE- pilocarpine hydrochloride ophthalmic solution solution/ drops United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride- pilocarpine hydrochloride ophthalmic solution solution/ drops

somerset therapeutics, llc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride ophthalmic solution, is indicated for the: none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pilocarpine hydrochloride ophthalmic solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pilocarpine hydrochloride ophthalmic solution is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

PILOCARPINE HYDROCHLORIDE solution/ drops United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride solution/ drops

amneal pharmaceuticals ny llc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride ophthalmic solution is indicated for the: none. pregnancy category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pilocarpine hydrochloride ophthalmic solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pilocarpine hydrochloride ophthalmic solution is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established.   no overall differences in safety or effectiveness have been observed between elderly and younger patients.

PILOCARPINE HYDROCHLORIDE solution/ drops United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride solution/ drops

amneal pharmaceuticals ny llc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride ophthalmic solution is indicated for the: none. pregnancy category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pilocarpine hydrochloride ophthalmic solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pilocarpine hydrochloride ophthalmic solution is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established.   no overall differences in safety or effectiveness have been observed between elderly and younger patients.

CARDILOC 5 Israel - English - Ministry of Health

cardiloc 5

unipharm ltd, israel - bisoprolol fumarate - tablets - bisoprolol fumarate 5 mg - bisoprolol - bisoprolol - management of angina pectoris, hypertention. treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.

CARDILOC 10 Israel - English - Ministry of Health

cardiloc 10

unipharm ltd, israel - bisoprolol fumarate - tablets - bisoprolol fumarate 10 mg - bisoprolol - management of angina pectoris, hypertention. treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.

CARDILOC 10 Israel - English - Ministry of Health

cardiloc 10

unipharm ltd, israel - bisoprolol fumarate - tablets - bisoprolol fumarate 10 mg - bisoprolol - management of angina pectoris, hypertention. treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.

CARDILOC 2.5 Israel - English - Ministry of Health

cardiloc 2.5

unipharm ltd, israel - bisoprolol hemifumarate - tablets - bisoprolol hemifumarate 2.5 mg - bisoprolol - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.